Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
Creator
Jiang, Shibo
Wang, Chao
Zhong, Wu
Xia, Shuai
Liang, Guodong
Zhao, Lei
Liu, Keliang
Zhang, Tianhong
Cao, Ruiyuan
Li, Yue
Meng, Guangpeng
Shi, Weiguo
Wang, Weicong
Source
Medline; PMC
abstract
[Image: see text] Class I enveloped viruses share similarities in their apparent use of a hexameric coiled-coil assembly to drive the merging of virus and host cell membranes. Inhibition of coiled coil-mediated interactions using bioactive peptides that replicate an α-helical chain from the viral fusion machinery has significant antiviral potential. Here, we present the construction of a series of lipopeptides composed of a de novo heptad repeat sequence-based α-helical peptide plus a hydrocarbon tail. Promisingly, the constructs adopted stable α-helical conformations and exhibited relatively broad-spectrum antiviral activities against Middle East respiratory syndrome coronavirus (MERS-CoV) and influenza A viruses (IAVs). Together, these findings reveal a new strategy for relatively broad-spectrum antiviral drug discovery by relying on the tunability of the α-helical coiled-coil domains present in all class I fusion proteins and the amphiphilic nature of the individual helices from this multihelix motif.
has issue date
2018-09-07
(
xsd:dateTime
)
bibo:doi
10.1021/acs.jmedchem.8b00890
bibo:pmid
30192544
has license
green-oa
sha1sum (hex)
54f1fd5d2fc81ab76c7139c4d3d2605d085d3e54
schema:url
https://doi.org/10.1021/acs.jmedchem.8b00890
resource representing a document's title
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
has PubMed Central identifier
PMC7075651
has PubMed identifier
30192544
schema:publication
Journal of Medicinal Chemistry
resource representing a document's body
covid:54f1fd5d2fc81ab76c7139c4d3d2605d085d3e54#body_text
is
schema:about
of
named entity 'SPECTRUM'
named entity 'DRUG DISCOVERY'
named entity 'hexameric'
named entity 'potential'
named entity 'replicate'
named entity 'chain'
named entity 'nature'
named entity 'coiled-coil'
named entity 'Novo'
named entity 'HELICAL'
named entity 'VIRAL FUSION PROTEINS'
named entity 'LIPOPEPTIDES'
named entity 'VIRAL'
named entity 'HERE'
named entity 'SERIES'
covid:arg/54f1fd5d2fc81ab76c7139c4d3d2605d085d3e54
named entity 'TARGETING'
named entity 'CHAIN'
named entity 'ANTIVIRAL DRUG'
named entity 'SPECTRUM'
named entity 'INFLUENZA A'
named entity 'COILED COIL'
named entity 'REPEAT SEQUENCE'
named entity 'PROTEINS'
named entity 'SIGNIFICANT'
named entity 'ACTIVITIES'
named entity 'ANTIVIRAL DRUG'
named entity 'DESIGN'
named entity 'MACHINERY'
named entity 'PEPTIDES'
named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS'
named entity 'DE NOVO'
named entity 'POTENTIAL'
named entity 'HELICES'
named entity 'STRATEGY'
named entity 'LIPOPEPTIDES'
named entity 'USING'
named entity 'HYDROCARBON'
named entity 'SHARE'
named entity 'INHIBITION'
named entity 'DE NOVO'
named entity 'FINDINGS'
named entity 'CLASS I'
named entity 'DRIVE'
named entity 'HELICAL'
named entity 'APPARENT'
named entity 'MEDIATED'
named entity 'INDIVIDUAL'
named entity 'CELL MEMBRANES'
named entity 'NEW'
named entity 'STRATEGY'
named entity 'MERGING'
named entity 'COMPOSED OF'
named entity 'HOST CELL'
named entity 'THEIR'
named entity 'DRUG DISCOVERY'
named entity 'BROAD'
named entity 'BASED'
named entity 'VIRUS'
named entity 'STABLE'
named entity 'NATURE'
named entity 'CONSTRUCTION'
named entity 'TAIL'
named entity 'ASSEMBLY'
named entity 'FUSION'
named entity 'INTERACTIONS'
named entity 'REPLICATE'
named entity 'BROAD'
named entity 'ADOPTED'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 11
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software